Feb 6, 2026
Pharmaceutical company drug trial results challenged by independent analysis of individual patient data
Independent re-analyses of individual patient data (IPD) have increasingly exposed and what deeper data show, prompting regulatory delays, legal scrutiny and calls for stronger transparency rules . Wh...